1-Day Conference

Internal Medicine Update

AMA PRA Category 2 Credit

A focused Internal Medicine day covering risk-based prevention, cardiometabolic therapy, outpatient infectious diseases, and geriatric complexity with deprescribing.

internal medicine

preventive care

cardiometabolic management

infectious diseases outpatient

geriatrics deprescribing

Destination

Dates

$400

About this Conference

This virtual Internal Medicine program delivers practical updates across prevention, cardiometabolic care, infectious diseases commonly seen in the clinic, and care for older adults with multimorbidity. Each hour blends concise frameworks with decision-ready algorithms and patient-matching strategies. The day emphasizes guideline-concordant care, safe prescribing, and measurable practice change.

7:00 AM - 11:45 AM
Schedule (Local Time): 16 Workshops
Number of Subjects: Online Course
Course Type: New York
Destination

Destination

1-Day Schedule

Conference Outline

Day 1

A focused Internal Medicine day covering risk-based prevention, cardiometabolic therapy, outpatient infectious diseases, and geriatric complexity with deprescribing.

Section 1

Preventive Care & Risk Stratification in Adults

Evidence-based screening, vaccination, and lifestyle counseling for adults, including ASCVD risk estimation and prioritization of the highest-value preventive services.

7:00 AM —8:00 AM60 Minutes

Calculate ASCVD risk and align screening intervals to patient risk and life expectancy.
Implement adult immunization schedules and same-day catch-up strategies.
Use shared decision-making to initiate or defer preventive medications such as statins and aspirin.

Risk-Based Screening & ASCVD Estimation

Use pooled cohort equations and risk enhancers to prioritize screening schedules and preventive interventions.

7:00 AM15 Minutes

Estimate 10-year ASCVD risk and identify risk enhancers.
Adjust screening intervals based on individualized risk.
Communicate absolute risk and expected benefit using plain-language visuals.

screening intervals

ascvd estimation

primary prevention

Adult Immunizations: What’s Due Today

Operationalize adult vaccine updates, catch-up dosing, and coadministration in primary care workflows.

7:15 AM15 Minutes

Identify vaccine indications and contraindications by age and risk.
Implement catch-up and coadministration protocols.
Close vaccination gaps using standing orders and reminders.

immunization

vaccine schedules

practice workflow

Cancer Screening: CRC, Cervical, Lung—Who, When, How

Translate guidelines for CRC, cervical, and lung cancer screening into clear eligibility and modality choices.

7:30 AM15 Minutes

Determine eligibility and intervals for CRC, cervical, and lung screening.
Choose appropriate screening modalities based on risk and access.
Address over-screening and de-implementation where harms outweigh benefits.

colorectal cancer screening

cervical cancer screening

lung cancer screening

Shared Decision-Making for Preventive Medications

Initiation and de-escalation of statins, aspirin, and other preventive medications using patient-centered tradeoffs.

7:45 AM15 Minutes

Initiate or defer statins and aspirin based on absolute risk and bleeding risk.
Counsel using absolute risk reduction and NNT.
Document shared decisions that reflect patient goals.

statins primary prevention

aspirin prevention

shared decision making

—

Break

8:00 AM15 minutes

Section 2

Core Cardiometabolic Therapy: Hypertension, Diabetes, Lipids, Obesity

Drug selection and escalation across hypertension, type 2 diabetes, dyslipidemia, and obesity with goal-driven titration and patient matching.

8:15 AM —9:15 AM60 Minutes

Select first-line agents and targets for hypertension based on comorbidities.
Initiate and adjust GLP-1/SGLT2 therapy for T2D with cardio-renal indications.
Optimize LDL lowering for primary prevention using statins and add-on therapies.

Hypertension: Targets & First-line Choices

Set BP goals and choose initial therapy considering CKD, CAD, diabetes, and race/ethnicity nuances.

8:15 AM15 Minutes

Set individualized BP targets using current guideline ranges.
Select first-line agents based on comorbidities and demographics.
Plan follow-up and home BP monitoring to assess response.

hypertension

bp targets

initial therapy

Diabetes: Initiation & GLP-1/SGLT2 Patient Matching

Initiate metformin and advance to GLP-1/SGLT2 based on ASCVD, HF, CKD, weight, and hypoglycemia risk.

8:30 AM15 Minutes

Initiate and titrate first- and second-line agents aligned to comorbidities.
Mitigate adverse effects and drug–drug interactions.
Set A1C goals and early reassessment timelines.

type 2 diabetes

glp 1 receptor agonists

sglt2 inhibitors

Hyperlipidemia: Primary Prevention LDL Strategy

Risk-stratify and select statin intensity; consider ezetimibe/PCSK9 add-ons for selected patients.

8:45 AM15 Minutes

Calculate risk and choose appropriate statin intensity.
Identify indications for nonstatin add-ons.
Address statin intolerance with practical alternatives.

dyslipidemia

ldl lowering

primary prevention

Obesity Pharmacotherapy & Cardiometabolic Risk

Use anti-obesity medications to improve weight and cardio-renal outcomes, with safety monitoring and switching strategies.

9:00 AM15 Minutes

Identify candidates and contraindications for anti-obesity medications.
Monitor efficacy and adverse events and decide when to switch or combine.
Counsel on lifestyle supports to sustain pharmacologic benefits.

obesity pharmacotherapy

weight management

cardiometabolic risk

—

Break

9:15 AM15 minutes

Section 3

Infections You See This Month: Outpatient ID & Stewardship

High-yield outpatient management of CAP, UTIs, and cellulitis, plus antiviral use and antimicrobial stewardship to reduce resistance and harms.

9:30 AM —10:30 AM60 Minutes

Diagnose and treat outpatient CAP using severity criteria and local resistance patterns.
Differentiate uncomplicated and complicated UTIs and select empiric therapies.
Implement stewardship practices for antibiotics and antivirals in ambulatory care.

CAP in the Clinic: Who Needs Antibiotics & Which

Apply severity tools and comorbidity flags to select oral regimens and define when to image or refer.

9:30 AM15 Minutes

Stratify CAP severity and decide on outpatient management.
Select empiric therapy aligned with risk factors and resistance.
Set reassessment and safety-net criteria.

community acquired pneumonia

antibiotic selection

severity assessment

UTIs: Uncomplicated vs Complicated, When to Culture

Differentiate cystitis from pyelonephritis, select empiric agents, and know when urine culture changes management.

9:45 AM15 Minutes

Classify UTI type and identify red flags.
Choose empiric therapy while minimizing collateral damage.
Order urine cultures when results will change therapy.

urinary tract infections

cystitis

pyelonephritis

Cellulitis/Abscess: Oral vs IV, MRSA Coverage

Recognize purulent vs nonpurulent infection, need for I&D, and when to add MRSA coverage or escalate care.

10:00 AM15 Minutes

Differentiate cellulitis subtypes and indications for I&D.
Select oral vs IV therapy and MRSA coverage when indicated.
Define follow-up and criteria for treatment failure.

skin soft tissue infections

mrsa

incision and drainage

Antiviral Use & Stewardship: Flu & COVID-19

When to test, treat, or observe for influenza and COVID-19; eligibility for antivirals; and minimizing unnecessary prescribing.

10:15 AM15 Minutes

Identify patients who benefit from influenza and COVID-19 antivirals.
Apply drug–drug interaction checks and renal/hepatic dosing.
Embed stewardship nudges in outpatient workflows.

influenza

covid 19 outpatient

antimicrobial stewardship

—

Break

10:30 AM15 minutes

Section 4

Caring for Complexity: Geriatrics, Multimorbidity & Deprescribing

CGA-driven care for frailty, falls, delirium, and optimization of CKD and HF medications with safer prescribing and advance care planning.

10:45 AM —11:45 AM60 Minutes

Perform a brief CGA to identify frailty, functional risk, and medication-related harms.
Prevent and manage falls and delirium using targeted interventions.
Deprescribe high-risk medications and align care with goals and prognosis.

Frailty & Functional Assessment: CGA in 10 Minutes

A rapid approach to CGA to surface functional risks, polypharmacy issues, and social needs.

10:45 AM15 Minutes

Screen for frailty and functional decline with brief tools.
Identify medications contributing to impairment.
Initiate referrals to PT/OT and community supports.

comprehensive geriatric assessment

frailty

functional status

Falls & Delirium: Evaluate, Prevent, and Treat

Risk-factor–based evaluation and practical inpatient-to-home prevention bundles for falls and delirium.

11:00 AM15 Minutes

Perform targeted evaluation for falls and delirium etiologies.
Start multi-component prevention strategies.
Create follow-up plans to monitor resolution and recurrence.

falls

delirium

risk reduction

CKD & HFrEF: Safer Prescribing and Dosing

Dose-adjust nephrotoxic and cardioactive medications and integrate SGLT2 where indicated for kidney and HF protection.

11:15 AM15 Minutes

Adjust medication dosing for CKD and HFrEF and avoid common nephrotoxins.
Recognize indications for SGLT2 in CKD and HF.
Monitor labs and symptoms to prevent adverse drug events.

chronic kidney disease

heart failure reduced ef

medication safety

Deprescribing & Advance Care Planning

Use structured deprescribing algorithms and goal-concordant planning to simplify regimens and reduce harm.

11:30 AM15 Minutes

Identify high-risk medications and apply deprescribing algorithms.
Conduct brief goals-of-care discussions tied to medication changes.
Document and communicate plans across care settings.

deprescribing

advance care planning

polypharmacy

—

End of Day

End of day

11:45 AM

Key Objectives

Apply risk-based screening and vaccination schedules using ASCVD estimation and age/comorbidity frameworks.
Select and titrate guideline-concordant therapies for hypertension, type 2 diabetes, dyslipidemia, and obesity using patient-matching to GLP-1/SGLT2 agents.
Manage common outpatient infections and implement deprescribing strategies for older adults with multimorbidity.

Virtual Conferences

Flexible Destination-Based Learning

549 Destinations Available

Our conferences are delivered entirely online through short, high-impact video sessions. Designed for travelers and professionals on the go, each module is just 15 minutes—so you can complete your learning in the morning and spend the rest of your day enjoying the destination.

Satisfaction Guaranteed

Reschedule or Cancel Anytime

Easily reschedule or apply your credit to another class—no hassle, no stress. If you prefer a refund, we offer a full return minus a $30 processing fee—because we know you value flexibility.

Frequently asked questions

Can’t find the answer you’re looking for? Reach out to our customer support team.

How does destination-based learning work?: Destination-based learning is a teaching method that involves students traveling to a specific location to learn about a particular subject. This method allows students to gain a deeper understanding of the subject by experiencing it firsthand.
Is this conference live?: Conferences are scheduled and attended at their designated time and locations. Attendees participate from the designated location of the event and experience expert-reviewed content in real-time.
Is my travel and lodging included?: Pricing is for the conference itself. Travel and lodging are not included but for some destinations we offer partnership benefits and discounts.
Can I change the destination or scheduled date later?: You can easily change the destination or scheduled date for no fee. You can also request a full refund minus a $30 processing fee.